Biotechnology
Compare Stocks
2 / 10Stock Comparison
PTN vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
PTN vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Biotechnology |
| Market Cap | $10M | $1721.78T |
| Revenue (TTM) | $9M | $0.00 |
| Net Income (TTM) | $-10M | $-168M |
| Gross Margin | 99.2% | — |
| Operating Margin | -134.8% | — |
| Total Debt | $164K | $22M |
| Cash & Equiv. | $3M | $194M |
PTN vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Palatin Technologie… (PTN) | 100 | 149.0 | +49.0% |
| DBV Technologies S.… (DBVT) | 100 | 41.4 | -58.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PTN vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PTN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.20
- Rev growth -100.0%, EPS growth -14.9%
- 38.2% 10Y total return vs DBVT's -86.8%
DBVT is the clearest fit if your priority is quality.
- 0.3% margin vs PTN's -107.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -100.0% revenue growth vs DBVT's -100.0% | |
| Quality / Margins | 0.3% margin vs PTN's -107.4% | |
| Stability / Safety | Beta 0.20 vs DBVT's 1.26 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +110.8% vs DBVT's +114.1% | |
| Efficiency (ROA) | -53.7% ROA vs DBVT's -89.0% |
PTN vs DBVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PTN vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DBVT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
PTN and DBVT operate at a comparable scale, with $9M and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $9M | $0 |
| EBITDAEarnings before interest/tax | -$12M | -$112M |
| Net IncomeAfter-tax profit | -$10M | -$168M |
| Free Cash FlowCash after capex | -$16M | -$151M |
| Gross MarginGross profit ÷ Revenue | +99.2% | — |
| Operating MarginEBIT ÷ Revenue | -134.8% | — |
| Net MarginNet income ÷ Revenue | -107.4% | — |
| FCF MarginFCF ÷ Revenue | -177.2% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -19.7% | +91.5% |
Valuation Metrics
DBVT leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $10M | $1721.78T |
| Enterprise ValueMkt cap + debt − cash | $8M | $1721.78T |
| Trailing P/EPrice ÷ TTM EPS | -0.59x | -0.76x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | — | — |
| Price / BookPrice ÷ Book value/share | — | 0.66x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
Evenly matched — PTN and DBVT each lead in 3 of 6 comparable metrics.
Profitability & Efficiency
PTN delivers a -84.0% return on equity — every $100 of shareholder capital generates $-84 in annual profit, vs $-130 for DBVT. On the Piotroski fundamental quality scale (0–9), DBVT scores 4/9 vs PTN's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -84.0% | -130.2% |
| ROA (TTM)Return on assets | -53.7% | -89.0% |
| ROICReturn on invested capital | — | — |
| ROCEReturn on capital employed | — | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | — | 0.13x |
| Net DebtTotal debt minus cash | -$2M | -$172M |
| Cash & Equiv.Liquid assets | $3M | $194M |
| Total DebtShort + long-term debt | $163,781 | $22M |
| Interest CoverageEBIT ÷ Interest expense | -1244.69x | -189.82x |
Total Returns (Dividends Reinvested)
PTN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PTN five years ago would be worth $13,571 today (with dividends reinvested), compared to $3,344 for DBVT. Over the past 12 months, PTN leads with a +11076.5% total return vs DBVT's +114.1%. The 3-year compound annual growth rate (CAGR) favors PTN at 103.3% vs DBVT's 6.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +18.4% | +5.5% |
| 1-Year ReturnPast 12 months | +11076.5% | +114.1% |
| 3-Year ReturnCumulative with dividends | +740.7% | +20.4% |
| 5-Year ReturnCumulative with dividends | +35.7% | -66.6% |
| 10-Year ReturnCumulative with dividends | +38.2% | -86.8% |
| CAGR (3Y)Annualised 3-year return | +103.3% | +6.4% |
Risk & Volatility
Evenly matched — PTN and DBVT each lead in 1 of 2 comparable metrics.
Risk & Volatility
PTN is the less volatile stock with a 0.20 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBVT currently trades 76.8% from its 52-week high vs PTN's 61.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.20x | 1.26x |
| 52-Week HighHighest price in past year | $31.00 | $26.18 |
| 52-Week LowLowest price in past year | $0.04 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +61.3% | +76.8% |
| RSI (14)Momentum oscillator 0–100 | 47.1 | 43.8 |
| Avg Volume (50D)Average daily shares traded | 15K | 253K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $46.33 |
| # AnalystsCovering analysts | — | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
DBVT leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). PTN leads in 1 (Total Returns). 2 tied.
PTN vs DBVT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is PTN or DBVT a better buy right now?
Analysts rate DBV Technologies S.
A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — PTN or DBVT?
Over the past 5 years, Palatin Technologies, Inc.
(PTN) delivered a total return of +35. 7%, compared to -66. 6% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: PTN returned +38. 2% versus DBVT's -86. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — PTN or DBVT?
By beta (market sensitivity over 5 years), Palatin Technologies, Inc.
(PTN) is the lower-risk stock at 0. 20β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 521% more volatile than PTN relative to the S&P 500.
04Which is growing faster — PTN or DBVT?
On earnings-per-share growth, the picture is similar: DBV Technologies S.
A. grew EPS -347. 5% year-over-year, compared to -1491. 6% for Palatin Technologies, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — PTN or DBVT?
DBV Technologies S.
A. (DBVT) is the more profitable company, earning 0. 0% net margin versus -107. 4% for Palatin Technologies, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DBVT leads at 0. 0% versus -134. 8% for PTN. At the gross margin level — before operating expenses — PTN leads at 99. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — PTN or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is PTN or DBVT better for a retirement portfolio?
For long-horizon retirement investors, Palatin Technologies, Inc.
(PTN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 20)). Both have compounded well over 10 years (PTN: +38. 2%, DBVT: -86. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between PTN and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.